Technology transfer

Delta Secures License to Hydrogen Energy Technology from UK-listed Ceres to Develop its Fuel Cell and Electrolysis Solutions

Retrieved on: 
Thursday, January 18, 2024
Hydrogen, Technology transfer, London Stock Exchange, SOEC, Temperature, Electricity, Partnership, ICE, Electronics, Delta Electronics, Methane, Ship, Carbon, Water, Steel, Transport, Transmission loss

Ceres is a global leader in solid oxide fuel cell and electrochemical technology.

Key Points: 
  • Ceres is a global leader in solid oxide fuel cell and electrochemical technology.
  • Through this partnership, Delta expects to integrate Ceres' energy stack technology with its own industry-leading power electronics and thermal management technologies to develop solid oxide fuel cell (SOFC) and solid oxide electrolysis cell (SOEC) systems for hydrogen energy applications, with production expected to start by the end of 2026, with strong ambition for future scale-up.
  • These SOFC and SOEC systems are expected to enhance the capabilities of Delta's green solutions for a myriad of sectors, such as, chemicals, energy, transportation, steel and more.
  • We believe Delta can deliver efficient clean hydrogen solutions for its customers utilising both our SOFC and SOEC technologies.

CELLIPONT BIOSERVICES SELECTS L7 INFORMATICS FOR ITS FLEXIBLE AND UNIFIED PLATFORM, ENABLING END-TO-END MANUFACTURING

Retrieved on: 
Wednesday, January 17, 2024
Research, Technology transfer, Data management, Partnership, Education minister, Knowledge management, Manufacturing execution system, MES, Organization, CDMO, Informatics

This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics' L7|ESP™ unified platform and its integrated Manufacturing Execution System (MES) application to digitalize its cell therapy manufacturing recipes, streamline technology transfers, and digitally enable its customers.

Key Points: 
  • This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics' L7|ESP™ unified platform and its integrated Manufacturing Execution System (MES) application to digitalize its cell therapy manufacturing recipes, streamline technology transfers, and digitally enable its customers.
  • The deployment of L7|ESP by Cellipont signifies a significant step towards optimizing cell therapy development and manufacturing processes.
  • By integrating L7 Informatics' advanced platform, Cellipont Bioservices aims to elevate the quality and efficiency of its services, contributing to advancements in cell therapy development and manufacturing methods and technologies.
  • Follow L7 Informatics for more information , or contact the team to learn more about L7|ESP capabilities .

Revive Therapeutics Successfully Completes Development of a Novel Lyophilized Formulation of Bucillamine

Retrieved on: 
Wednesday, January 10, 2024
Organ transplantation, RVV, Technology transfer, Research, University, Injury, Inflammation, Public, Infection, National security, Disorder, Solubility, FDA, Therapy, Defense, Inclusion, Trial of the century, Pharmaceutical industry

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has completed the formulation development work of the Company’s next-generation lyophilized formulation of Bucillamine (“New Bucillamine”) conducted at the University of Waterloo.

Key Points: 
  • TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has completed the formulation development work of the Company’s next-generation lyophilized formulation of Bucillamine (“New Bucillamine”) conducted at the University of Waterloo.
  • The New Bucillamine has the potential to unlock the therapeutic utility of Bucillamine for treating public health medical emergencies, including pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks.
  • Key research findings and observations include:
    Lyophilization of Bucillamine enhances solubility 2.7x compared to standard solution of Bucillamine;
    Inclusion of lyophilization in the Bucillamine formulation approach can result in an ability to increase Bucillamine delivery per dosing unit; and
    Inclusion of lyophilization in the Bucillamine formulation approach offers a simple way to create a parenteral injection product with minimal formulation additives.
  • Also, the Company may explore the New Bucillamine as a potent antioxidant and anti-inflammatory, for rare inflammatory disorders such as ischemia-reperfusion injury (i.e.

COP28: A Victory for the Coalition for Rainforest Nations and the Paris Agreement

Retrieved on: 
Tuesday, January 9, 2024
Automotive, Environmental Policy, Environmental Issues, Forest Products, Agriculture, Natural Resources, Alternative Vehicles, Fuels, Alternative Energy, Environment, Energy, Sustainability, Consensus, European, Technology transfer, COP28, Global stocktake, Temperature, Accounting, School, UN, Paris Agreement, Carbon, Consensus decision-making, GST, UNFCCC, Poverty, Renewable energy

After two weeks of negotiations, countries agreed to their response to the first Global Stocktake (GST) under the Paris Agreement.

Key Points: 
  • After two weeks of negotiations, countries agreed to their response to the first Global Stocktake (GST) under the Paris Agreement.
  • In addition to transitioning away from fossil fuels in energy systems, the UAE Consensus affirmed the urgent need to reverse global deforestation by 2030 through the Paris Agreement.
  • While the final agreement did not go as far as many had wished in terms of phasing out fossil fuels, it was nonetheless historic.
  • The final text, for first time, included the need for all countries to transition away from fossil fuels by 2050 and towards renewables and energy efficiency.

Sigmetrix Announces Partnership with E-SOFT in Paris, France

Retrieved on: 
Wednesday, January 10, 2024
Partnership, Geometric dimensioning and tolerancing, Engineering, Technology transfer, Research, Airline

MCKINNEY, Texas, Jan. 10, 2024 /PRNewswire-PRWeb/ -- Sigmetrix, a global leader in mechanical variation and tolerance analysis software, is thrilled to announce the partnership of E-SOFT France, its new subsidiary based in Paris. This strategic development marks an intensified collaboration with EnginSoft across Europe, aiming to enhance the accessibility of cutting-edge engineering software solutions and dedicated support services for clients in the region.

Key Points: 
  • Sigmetrix announces the addition of E-SOFT France, Its New French Subsidiary in Paris.
  • MCKINNEY, Texas, Jan. 10, 2024 /PRNewswire-PRWeb/ -- Sigmetrix , a global leader in mechanical variation and tolerance analysis software, is thrilled to announce the partnership of E-SOFT France, its new subsidiary based in Paris.
  • "We are excited about the expanded partnership with EnginSoft and the launch of E-SOFT France.
  • Clients in Europe can now expect even greater support and training opportunities, leveraging the joint capabilities of Sigmetrix and EnginSoft through E-SOFT France.

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

Retrieved on: 
Monday, January 8, 2024
Marketing, Associate, PEGylation, Commercial, Biotechnology, Spacecraft, Pennsylvania State University, Quality management system, Binghamton University, Ania, Control, Technology transfer, Annual report, Robert Morris University, CMC, Lehigh University, University, Region, Doctor of Philosophy, Therapy, Scorpius, PPQ, Patheon, Chemical engineering, Rutgers University, Computer science, Biochemical engineering, Research, GMP, WuXi AppTec, Business development, Quality assurance, Growth, Investment, Bristol Myers Squibb

The Company will continue to operate its CDMO within the Scorpius BioManufacturing subsidiary.

Key Points: 
  • The Company will continue to operate its CDMO within the Scorpius BioManufacturing subsidiary.
  • Jeff Wolf, CEO of Nighthawk, commented, “Our rebranding to Scorpius Holdings is a testament to our successful transition and the growth of our CDMO operations.
  • The industry faces a critical shortage of clinical-scale biologic manufacturing capacity, driven by increasing demand for large molecule CDMO services.
  • Our state-of-the-art facility in San Antonio, Texas ideally positions us to address this gap in CDMO manufacturing capacity and services.

Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.

Retrieved on: 
Thursday, January 4, 2024
Technology transfer, Thermo Fisher Scientific, Research, TMO, Galapagos NV, Euronext, GMP, Patient, Pharmaceutical industry

Mechelen, Belgium; 4 January 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration agreement with Thermo Fisher Scientific, Inc. (NYSE: TMO) (“Thermo Fisher”) for the decentralized manufacturing of Galapagos’ point-of-care CAR-T product candidate in the San Francisco area.

Key Points: 
  • Mechelen, Belgium; 4 January 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration agreement with Thermo Fisher Scientific, Inc. (NYSE: TMO) (“Thermo Fisher”) for the decentralized manufacturing of Galapagos’ point-of-care CAR-T product candidate in the San Francisco area.
  • Under the terms of the agreement, Thermo Fisher will provide GMP manufacturing as well as BioServices and Specialty Logistics for Galapagos’ CAR-T hemato-oncology clinical program in the San Francisco area, effective January 2024.
  • Galapagos will initiate the technology transfer to enable Thermo Fisher’s manufacturing activities.
  • This collaboration follows Galapagos’ agreement with Landmark Bio for decentralized CAR-T manufacturing in the Boston area announced in November 2023.

SAIC to Support the U.S. Navy’s Hypersonics Advanced Concepts and Strategic Missions Programs

Retrieved on: 
Thursday, January 4, 2024
Technology, Engineering, Aerospace, Manufacturing, Military, Artificial Intelligence, Defense, Other Technology, Other Defense, Software, Contracts, Hardware, Other Manufacturing, Government Technology, Annual report, Technology transfer, Ecosystem, Culture, Newsroom, Risk, System, Naval Surface Warfare Center, Research, NSWC, SAIC, Result, Analysis, News, Application, HWIL, Artificial intelligence, Intelligence, SSP, Department of Defence, Comment, Management

Science Applications International Corp. (NYSE: SAIC ) has been awarded a $63 million contract from the U.S. Navy to support hypersonics advanced concepts and strategic mission solutions for the Navy’s Strategic Systems Programs (SSP) and the Naval Surface Warfare Center (NSWC) Crane, Ind., Strategic Systems Hardware Division (GXW).

Key Points: 
  • Science Applications International Corp. (NYSE: SAIC ) has been awarded a $63 million contract from the U.S. Navy to support hypersonics advanced concepts and strategic mission solutions for the Navy’s Strategic Systems Programs (SSP) and the Naval Surface Warfare Center (NSWC) Crane, Ind., Strategic Systems Hardware Division (GXW).
  • “Every day, SAIC provides expertise in systems integration and delivery solutions in support of the U.S. Navy’s strategic priorities,” said Barbara Supplee, senior vice president, Navy Business Group at SAIC.
  • SAIC’s continuing support to NSWC Crane will also include developing unique test capabilities, assessing and addressing technology gaps, recommending requirements and solutions for hypersonics advanced concepts and strategic mission areas, identifying critical enabling technologies and assessing a technology’s suitability for specific applications including flight qualification.
  • SAIC will assist SSP and NSWC Crane in driving quick-reaction analysis and rapid engineering principals across Department of Defense hypersonic advanced concepts and strategic mission initiatives to enable continued technological superiority.

National Industry Leaders Welcome Japan, UK & Italy Government Agreement on the Next Generation Global Combat Air Programme

Retrieved on: 
Friday, December 15, 2023
Mitsubishi Heavy Industries, Technology transfer, Partnership, GCAP, Convention, GIGO, BAE Systems, Aircraft, Fellow, Knowledge, Arms industry

TOKYO, Dec 15, 2023 - (JCN Newswire) - The national defence industry leaders on the Global Combat Air Programme (GCAP) - Mitsubishi Heavy Industries (Japan), BAE Systems (UK) and Leonardo (Italy) - have warmly welcomed the signing of the Convention on the Establishment of the "Global Combat Air Programme - GCAP International Government Organisation (the GIGO)" by their respective governments.

Key Points: 
  • TOKYO, Dec 15, 2023 - (JCN Newswire) - The national defence industry leaders on the Global Combat Air Programme (GCAP) - Mitsubishi Heavy Industries (Japan), BAE Systems (UK) and Leonardo (Italy) - have warmly welcomed the signing of the Convention on the Establishment of the "Global Combat Air Programme - GCAP International Government Organisation (the GIGO)" by their respective governments.
  • Ministers from Japan, UK and Italy signed the treaty, which marks an important agreement in the shared design and delivery of a next generation fighter aircraft by 2035.
  • The agreement, signed just 12 months since the formation of the GCAP programme, reinforces its momentum and the strong trilateral cooperation amongst the partners.
  • The Global Combat Air Programme is a hugely significant programme for the security, political and economic prosperity for Japan, UK and Italy and through effective knowledge and technology transfer will help to evolve and deliver important sovereign combat air capability in each nation for generations to come.

Yazaki Corporation and NEC use AI to automatically develop operation plans for multiple robots

Retrieved on: 
Thursday, November 9, 2023
Car, Technology transfer, AI, Carbon, NEC, Yazaki

TOKYO, Nov 9, 2023 - (JCN Newswire) - Yazaki Corporation (Yazaki) and NEC Corporation (NEC; TSE: 6701) have conducted a demonstration experiment using the "NEC Digital Robot Motion Planning Solution" to automatically generate motion plans for multiple robots using AI in the manufacture of wire harnesses(1) for automobiles.

Key Points: 
  • TOKYO, Nov 9, 2023 - (JCN Newswire) - Yazaki Corporation (Yazaki) and NEC Corporation (NEC; TSE: 6701) have conducted a demonstration experiment using the "NEC Digital Robot Motion Planning Solution" to automatically generate motion plans for multiple robots using AI in the manufacture of wire harnesses(1) for automobiles.
  • This will be the first full-scale use in Japan(2) of a solution that uses AI to automatically generate motion plans for multiple robots to support the manufacture of multiple types of wire harnesses.
  • This system was realized by combining the NEC Digital Robot Motion Planning Solution with a robot system and simulator for wire harness assembly at Yazaki Corporation.
  • Yazaki will utilize multiple robots to promote flexible and rapid responses to the needs of variable-type, variable-volume production.